Hyperpigmentation and hypopigmentation disorders represent significant dermatological concerns, particularly within populations with skin of color. This clinical review aims to elucidate the pathophysiology, clinical manifestations, diagnostic approaches, and treatment modalities associated with these pigmentary disorders. Hyperpigmentation, characterized by increased melanin production, often manifests as melasma, post-inflammatory hyperpigmentation (PIH), and lentigines. Conversely, hypopigmentation disorders, including vitiligo and albinism, result from decreased melanin synthesis and can lead to significant psychosocial impacts. The review comprehensively analyzes the etiology of these conditions, emphasizing the role of genetics, environmental factors, and inflammatory responses in their development. It also highlights the unique presentation of these disorders in darker skin types, which can complicate diagnosis and management. A thorough examination of diagnostic techniques, including dermoscopy and histopathological evaluation, is provided, underscoring the importance of accurate assessment in formulating effective treatment strategies. Treatment options for hyperpigmentation and hypopigmentation are discussed in detail, encompassing topical agents, procedural interventions, and lifestyle modifications. The review emphasizes the need for personalized treatment approaches that consider the patient’s skin type, degree of impairment, and individual preferences. Emerging therapies, including laser treatments and novel pharmacological agents, are also explored, alongside their efficacy and safety profiles in diverse populations. In conclusion, this review serves as a critical resource for clinicians, dermatologists, and healthcare professionals, enhancing their understanding of hyperpigmentation and hypopigmentation disorders in skin of color. By fostering a comprehensive understanding of these conditions, the review aims to improve clinical outcomes and patient satisfaction through informed, culturally competent care. Future research directions are suggested to address the existing gaps in knowledge and treatment efficacy in these populations, ultimately leading to enhanced therapeutic strategies and improved quality of life for affected individuals.
Callahan et al. (Fri,) studied this question.